STOCK TITAN

Accelevation Holdings (ACCV) SEC Filings

ACCV NASDAQ
Rhea-AI Summary

Accelevation Holdings Corp. (ACCV) was the subject of a Schedule 13G reporting beneficial ownership of 6,083,600 Class A common shares, or 5.1% of the class, by reporting persons FMR LLC and Abigail P. Johnson as of September 30, 2026. FMR LLC reported sole voting and dispositive power over 6,083,600 shares. Abigail P. Johnson reported sole dispositive power over the same number of shares and zero sole voting power. The report states that other persons have rights to dividends or sale proceeds, but no other person's interest exceeds 5% of the class.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Accelevation Holdings Corp. entered into a new senior secured credit agreement through its subsidiary Accelevation LLC, providing a $250.0 million term loan facility and a $400.0 million revolving facility. At closing, Accelevation LLC had borrowed $250.0 million under the term loan and $150.0 million under the revolver. Those borrowings, with cash on hand, repaid all obligations under the prior credit agreement and paid transaction expenses; the prior agreement was repaid in full and terminated on October 9, 2026.

The facilities mature October 9, 2031. The term loan amortizes in quarterly installments of $3.125 million beginning with the fiscal quarter ending March 31, 2027; the revolver does not amortize. Beginning with that quarter, covenants set a maximum total net leverage ratio of 4.00 to 1.00 and a minimum fixed charge coverage ratio of 1.25 to 1.00. Following a material acquisition with aggregate consideration above $100.0 million, the borrower may elect a 4.50-to-1.00 leverage limit for the first four fiscal quarters, including the quarter of the acquisition. Term SOFR loans carry a 2.25% margin until delivery of the compliance certificate for the quarter ending June 30, 2027, then a leverage-based margin of 1.50% to 2.50%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.55%
Tags
current report
-
Rhea-AI Summary

Accelevation Holdings Corp. (ACCV) Chief Financial Officer Kenneth D. Krause received an award of 1,206,272 restricted stock units (RSUs) on October 1, 2026. The reported resulting position was 1,206,272 RSUs. Each RSU represents the right to receive one share of Class A common stock upon vesting, subject to continued service through the applicable vesting date. The reported transaction price was $0.00 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
insider
Rhea-AI Summary

Accelevation Holdings Corp. (ACCV) Chief Executive Officer and director Michael Rubiera purchased 200,000 Class A shares directly at $18.0000 per share on October 1, 2026, through a directed share program tied to the initial public offering; his direct holdings afterward were 1,424,285 shares. His adult children separately purchased 3,200 shares at $18.0000 per share in their individual accounts. An irrevocable trust for his spouse held 68,823 shares. Rubiera disclaims beneficial ownership of the children's and trust-held shares except to the extent of his pecuniary interest. No Rule 10b5-1 plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
insider
-
Rhea-AI Summary

Accelevation Holdings Corp. (ACCV) director Ginger M. Jones purchased 10,000 shares of Class A Common Stock on October 1, 2026, at $18 per share through a directed share program in connection with the company’s initial public offering. Her directly held position after the purchase was 10,000 shares. No Rule 10b5-1 plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
insider
-
Rhea-AI Summary

Accelevation Holdings Corp. (ACCV) director Howard C. Heckes purchased 5,000 shares of Class A common stock at $18 per share on October 1, 2026. The purchase was made through a directed share program in connection with the company’s initial public offering. His reported direct holdings after the transaction were 5,000 shares; no Rule 10b5-1 plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
insider
Rhea-AI Summary

Accelevation Holdings Corp. director Paul D. Donahue purchased 7,000 shares of Class A common stock at $18 per share on October 1, 2026, through a directed share program in connection with the company’s initial public offering. His direct holdings after the purchase were 7,000 shares. No Rule 10b5-1 plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
insider
-
Rhea-AI Summary

Accelevation Holdings Corp. Chief Operating Officer Brent C. Jewell was granted 301,568 restricted stock units on October 1, 2026. Each RSU represents the right to receive one Class A common share upon vesting, subject to continued service through the applicable vesting date. He also purchased 2,500 Class A common shares at $18 per share on October 1, 2026, through a directed share program in connection with the company’s initial public offering. No Rule 10b5-1 plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
insider
-
Rhea-AI Summary

Accelevation Holdings Corp. (ACCV) had IPO-related ownership transactions dated October 1, 2026. Accelevation Investment Holdings LLC converted 11,988,001 Series B Units, together with an equal number of Class B common shares, into 11,988,001 Class A common shares on a one-for-one basis. Accelevation Cash Pubco Holdings LP and Accelevation Investment Holdings LLC sold 20,000,000 Class A shares at $18 per share in the IPO; the sale comprised 8,011,999 shares from Cash Pubco Holdings and 11,988,001 from Investment Holdings. Accelevation Pubco Holdings LP also distributed 2,808,499 Class A shares pro rata to its limited partners for no consideration. Director Robert S. Morris, who is OGP VIII, LLC’s managing member, was among the reporting persons. The reporting persons disclaim beneficial ownership except to the extent of their respective pecuniary interests.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.36%
Tags
insider
Rhea-AI Summary

Accelevation Holdings Corp. (ACCV) closed its IPO on October 1, 2026, and delivered the Firm Shares: the company sold 10,000,000 shares of Class A common stock and the selling stockholders sold 20,000,000 shares, at $18.00 per share. The selling stockholders also granted the underwriters a 30-day option to purchase up to 4,500,000 additional Class A shares.

In connection with the IPO, Accelevation issued 116,965,529 shares of Class B common stock to Accelevation Investment Holdings LLC in an unregistered issuance relying on Section 4(a)(2) and Rule 506. Seven directors—Manu Bettegowda, Matt Bujor, Robert Morris, Paul Donahue, Howard Heckes, Ginger Jones, and Martin Durkin—were appointed on September 29, 2026. The company also adopted amended and restated governing documents effective that day, entered registration rights, director nomination, tax receivable, exchange and LLC agreements, adopted its 2026 Omnibus Incentive Plan, and entered indemnification agreements with its directors and executive officers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.84%
Tags
current report

FAQ

How many Accelevation Holdings (ACCV) SEC filings are available on StockTitan?

StockTitan tracks 26 SEC filings for Accelevation Holdings (ACCV). Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Accelevation Holdings (ACCV)?

The most recent SEC filing for Accelevation Holdings (ACCV) was filed on November 5, 2026.